Proactive Investors - Run By Investors For Investors

LeanLife issues stock options

The company said it had granted incentive stock options to certain officers, directors and consultants
omega 3
Lean Life Health develops omega-3 products which can be formulated as liquids, emulsions or powders and used as food additives

LeanLife Health Inc (CSE:LLP) said Thursday that it has granted stock options to certain officers, directors and consultants, pursuant to its 10% rolling stock option plan. 

The company said certain officers, directors and consultants will be entitled to purchase a total of 4,900,000 common shares of the company at an exercise price of C$0.05 per share for a three-year-term.

READ: LeanLife Health taps Chris Nichols as operations advisor

The company said the term will expire on February 7, 2022.

Lean Life Health develops omega-3 products which can be formulated as liquids, emulsions or powders and used as food additives

Shares of LeanLife were up 11.1% at C$0.05 on Thursday. 

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

young girl with allergy
March 22 2019
The sell-off that followed the recent disappointment of Allergy’s PQ Birch jab means now might be a good time to invest, according to City broker finnCap
Callitas CEO James Thompson
July 20 2018
CannaStrips will generate near-term revenue, while the company’s blue-sky pharmaceutical assets and orphan drug are solid, long-term plays
scientist in lab
February 25 2019
Results from a 62-patient follow-up study are due shortly, while data from a 500-person-strong managed access programme should be available by the end of next year
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use